'Safety monitoring' diaporamas de présentation

PV of ARVs Global Picture

PV of ARVs Global Picture. Dr Paula Munderi WHO Training Course for Introducing Pharmacovigilance of HIV Medicines 23 - 28 November 2009, Dar Es Salaam. Acknowledgements sources of slide material. Published programme data WHO Progress report 2009 Francois Venter

495 views • 38 slides

Pierre C oletti FGMM-CFDT

449 views • 34 slides

FDA Industry Workshop Statistics in the FDA & Industry The Future

FDA Industry Workshop Statistics in the FDA & Industry The Future. David L DeMets, PhD Department of Biostatistics & Medical Informatics University of Wisconsin School of Medicine & Public Health. Topics. Training/Certification Needs Academic/Industry Collaborations

448 views • 32 slides

Welcome Acklands-Grainger April 16, 2003

Welcome Acklands-Grainger April 16, 2003. Technology Applications Advantage: VX500. Technology. Sensing. Technology. UV Lamp. Technology. UV Lamp. Technology. UV Lamp. Technology. UV Lamp. Technology. UV Lamp. Technology. +. -. UV Lamp. Technology. +. Positive electrode. -.

453 views • 32 slides

Data and Safety Monitoring

Data and Safety Monitoring. Laurie Shaker-Irwin, Ph.D., M.S. Research Subject Advocate Assistant Professor of Medicine Office of Research Participant Advocacy (ORPA) UCLA General Clinical Research Center. Goals.

1.21k views • 31 slides

Pharmacovigilance

Pharmacovigilance. Dr Mary Couper Quality Assurance and Safety of Medicines WHO. Procurement and Supply Management Plan. 2.6 Ensuring rational use of medicines

570 views • 30 slides

Friday, 4/8/2011 Professor Wyatt Newman

Smart Wheelchairs. Friday, 4/8/2011 Professor Wyatt Newman. Outline. What/Why Smart Wheelchairs? Incremental Modules Reflexive collision avoidance Localization, trajectory generation, steering and smart buildings Speech-driven wheelchair control Natural language interfaces .

429 views • 24 slides

Fall Protection Susan Harwood Grant Training Program 2013 Commercial Roof Fall Safety

Fall Protection Susan Harwood Grant Training Program 2013 Commercial Roof Fall Safety. Learning Objectives. Understand the difference between a low sloped roof and high slope roof Understand the responsibilities of the roof monitor Understand the requirements for warning line systems

794 views • 23 slides

Sevene E, Mariano A, Mola D Faculty of Medicine / Ministry of Health Pretoria, September 2004

PHARMACOVIGILANCE SYSTEM - MOZAMBIQUE. INTRODUCING PV INTO HIV/AIDS PROGRAMME. Sevene E, Mariano A, Mola D Faculty of Medicine / Ministry of Health Pretoria, September 2004. PHARMACOVIGILANCE SYSTEM - MOZAMBIQUE. INTRODUCTION. Population: 19 million Prevalence of HIV: 14%

236 views • 16 slides

A project of the Clinical Trials Transformation Initiative

Improving the System of Reporting and Interpreting Unexpected Serious Adverse Events to Investigators Conducting Research Under an IND. A project of the Clinical Trials Transformation Initiative. Background.

247 views • 13 slides

Criteria For Approval 45 CFR 46.111 21 CFR 56.111

Criteria For Approval 45 CFR 46.111 21 CFR 56.111. Minimized risks Reasonable risk/benefit ratio Equitable subject selection Informed consent process Informed consent documentation Data monitored for safety Confidentiality/privacy maintained Vulnerable populations protected.

287 views • 12 slides

Summary of Oct. 3 rd Presentations

Summary of Oct. 3 rd Presentations. Improving the System of Reporting and Interpreting Unexpected Serious Adverse Events to Investigators Conducting Research Under an IND. Goals of Project.

237 views • 11 slides

Regional Forums Deputy Secretary Disability, Housing and Community Services

284 views • 10 slides

What We Do: Safety 2011-2013

What We Do: Safety 2011-2013. LPRI Workshop St Petersbourg , 24-26 May 2011. A More Strategic Approach. ICAO Safety Framework Policy & Standardization Safety Analysis Safety Monitoring Implementation

228 views • 10 slides

RESCUE 4701 Adverse Event Reporting October 16, 2010

RESCUE 4701 Adverse Event Reporting October 16, 2010. Maria Oh, Director Protocol Development & Regulatory Compliance. Adverse Events. AE reporting requirements Major Adverse Cardiac Event (MACE) Primary endpoint Study-related procedures to CCTA Safety monitoring. Reporting.

237 views • 9 slides

Elizabeth Garrett-Mayer, PhD Professor of Biostatistics Hollings Cancer Center, Charleston, SC

Large Phase 1 Studies with Expansion Cohorts: Clinical, Ethical, Regulatory and Patient Perspectives Accelerating Anticancer Agent Development and Validation Workshop May 7, 2015. Elizabeth Garrett-Mayer, PhD Professor of Biostatistics Hollings Cancer Center, Charleston, SC.

248 views • 8 slides

VCH HED Documentation Changes: Education Tab Safety/Fall Risk

VCH HED Documentation Changes: Education Tab Safety/Fall Risk. Start With the Education Record Tab First. Upon admission, identify the appropriate Care Contacts for your patient. This information needs only to be entered once during the admission (unless there is a change).

195 views • 8 slides

The research team of professor Cheng Lianglun The Faculty of Automation

162 views • 8 slides

Steps that Precede Clinical Study Initiation (DSMB)

Steps that Precede Clinical Study Initiation (DSMB). Review, finalize, and submit: Protocol Response to summary statement concerns Human Subjects Protection Plan/ Safety Monitoring Plan Target Enrollment Form Human Subjects Training Certification

222 views • 2 slides

Background and Significance

Population Pharmacokinetics of Dexmedetomidine in Infants Following Open Heart Surgery Felice Su MD, Susan C. Nicolson MD, Jeffrey S. Barrett PhD, Peter C. Adamson MD, David S. Kang BS, Rodolfo Godinez MD PhD, Athena F Zuppa MD MSCE

156 views • 1 slides